Adtech developer Fringe81, whose backers include corporates NTT Docomo, Dentsu and Itochu, is set to float on the Tokyo Stock Exchange.

Tencent, JG Summit and Uni-President Enterprises are set to record exits as Sea, the internet services firm formerly known as Garena, files confidentially to float in the US.

Cancer therapy developer G1 Therapeutics has gone public in an initial public offering that gave an exit to long-time investor MedImmune Ventures.

The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.

The machine learning-equipped online lender is exploring a flotation in the US that will allow Sunshine Insurance and Fosun to exit.

The Motorola Solutions-backed gunshot detection software provider plans to raise up to $34.5m in an initial public offering on Nasdaq.

The neurological disorder drug developer has floated in an initial public offering that gave pharmaceutical companies Sanofi and Takeda exits.

The cancer-focused antibody developer has secured $58.5m in a US flotation that involved existing investors Celgene and Eli Lilly buying more than $7m of shares.

Big data software provider Cloudera has gone public, but the gap between its market cap and the valuation at which Intel invested three years ago may be an ill omen for backers of other unicorns.